Clinical review: Central hypothyroidism: pathogenic, diagnostic, and therapeutic challenges.

J Clin Endocrinol Metab

Department of Clinical Sciences and Community Health, University of Milan, 20122 Milan, Italy.

Published: September 2012

Context: Central hypothyroidism (CH) is a particular hypothyroid condition due to an insufficient stimulation by TSH of an otherwise normal thyroid gland. This condition raises several challenges for clinicians; therefore, a review of the most relevant findings on CH epidemiology, pathogenesis, and clinical management has been performed.

Methodology: The relevant papers were selected by a PubMed search using appropriate key words.

Main Findings: CH can be the consequence of various disorders affecting either the pituitary gland or the hypothalamus, but most frequently affecting both of them. CH is about 1000-fold rarer than primary hypothyroidism. Except for the neonatal CH due to biallelic TSHβ mutations, the thyroid hormone defect is rarely as profound as can be observed in some primary forms. In contrast with primary hypothyroidism, CH is most frequently characterized by low/normal TSH levels, and adequate thyroid hormone replacement is associated with the suppression of residual TSH secretion. Thus, CH often represents a clinical challenge because physicians cannot rely on the systematic use of the "reflex TSH strategy." The clinical management of CH is further complicated by the frequent combination with other pituitary deficiencies and their substitution.

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2012-1616DOI Listing

Publication Analysis

Top Keywords

central hypothyroidism
8
clinical management
8
primary hypothyroidism
8
thyroid hormone
8
clinical
4
clinical review
4
review central
4
hypothyroidism
4
hypothyroidism pathogenic
4
pathogenic diagnostic
4

Similar Publications

Autoimmune polyglandular syndromes (APS) are characterized by associations of two or more autoimmune diseases (AID). APS type 3 is characterized by the presence of autoimmune thyroid disease associated with other AID, excluding adrenal gland involvement. Here we report a case of a 64-year-old male, with history of type 1 diabetes mellitus (T1DM), diagnosed at the age of 32, who was referred to a Diabetes consultation in 2014 due to poor metabolic control.

View Article and Find Full Text PDF

Prevalence and associated factors of anxiety and depression among patients with hypothyroidism in Southern Iran.

BMC Psychiatry

January 2025

Social Determinants of Health Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.

Purpose: Depression and anxiety are the main disorders in patients suffering from hypothyroidism. These disorders can lead to increased patient suffering. Since hypothyroidism is one of the most prevalent endocrine diseases, controlling the metabolic variables that increase the severity of anxiety and depression is important.

View Article and Find Full Text PDF

Background And Objective: Gastric cancer (GC) remains a leading cause of morbidity and mortality worldwide. The current standard of care involves neoadjuvant chemotherapy (NACT) followed by radical gastrectomy. This study aims to evaluate the efficacy of neoadjuvant therapy with PD-1/PD-L1 inhibitors in comparison to chemotherapy alone for patients with locally advanced gastric cancer (LAGC).

View Article and Find Full Text PDF

Background: Rathke cleft cysts (RCCs) are benign sellar/suprasellar lesions that result from mucin-secreting vestigial remnants within the pars intermedia of the pituitary gland. When symptomatic, they can present with retro-orbital headaches, visual field defects, and/or pituitary dysfunction.

Observations: A 35-year-old female presented with subacute retro-orbital headache, right ptosis, and blurred vision.

View Article and Find Full Text PDF

Thyroid disorders and the incidence of type 2 diabetes: insights from a 10-year cohort study in Germany.

Endocr Connect

January 2025

K Kostev, Epidemiology, IQVIA, Frankfurt am Main, Germany.

Background: Thyroid dysfunctions, such as hypothyroidism, hyperthyroidism, are known to influence metabolism, but their long-term impact on the development of type 2 diabetes mellitus (T2D) in humans remains elusive. Thus, this study aimed to assess the cumulative incidence and association between thyroid disorders and T2D development.

Methods: We conducted a retrospective cohort study using data from the Disease Analyzer database (IQVIA™) from 2005 to 2022.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!